Interleukin-8 predicts short-term mortality in acute-on-chronic liver failure patients with hepatitis B-related-related cirrhosis background

References

• Moreau R, Gao B, Papp M, et al. Acute-on-chronic liver failure: a distinct clinical syndrome. J Hepatol. 2021;75 Suppl. 1(Suppl. 1):1–11. doi: 10.1016/j.jhep.2020.11.047.
   Google Scholar
• TRéPO C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–2063. doi: 10.1016/S0140-6736(14)60220-8.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update. Hepatol Int. 2019;13(4):353–390. doi: 10.1007/s12072-019-09946-3.
   PubMed Web of Science ®Google Scholar
• Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426–1437.e9. doi: 10.1053/j.gastro.2013.02.042.
   PubMed Web of Science ®Google Scholar
• Gustot T, Fernandez J, Garcia E, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62(1):243–252. doi: 10.1002/hep.27849.
   PubMed Web of Science ®Google Scholar
• Casulleras M, Zhang IW, LóPEZ-Vicario C, et al. Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure. Cells. 2020;9(12):2632. doi: 10.3390/cells9122632.
   PubMed Web of Science ®Google Scholar
• Triantafyllou E, Woollard KJ, Mcphail MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front Immunol. 2018;9:2948. (doi: 10.3389/fimmu.2018.02948.
   PubMed Web of Science ®Google Scholar
• Zhang IW, Curto A, LóPEZ-Vicario C, et al. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure. J Hepatol. 2022;76(1):93–106. doi: 10.1016/j.jhep.2021.08.009.
   PubMed Web of Science ®Google Scholar
• Hernandez-Mijares A, Rocha M, Rovira-Llopis S, et al. Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Diabetes Care. 2013;36(6):1695–1702. doi: 10.2337/dc12-1224.
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Claus K, Jansen C, et al. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality. Liver Int. 2018;38(5):875–884. doi: 10.1111/liv.13610.
   PubMed Web of Science ®Google Scholar
• Wu Z-B, Zheng Y-B, Wang K, et al. Plasma interleukin-6 level: a potential prognostic indicator of emergent HBV-Associated ACLF. Can J Gastroenterol Hepatol. 2021;2021:5545181–5545187. (doi: 10.1155/2021/5545181.
   PubMedGoogle Scholar
• Li J, Liang X, You S, et al. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure. J Hepatol. 2021;75(5):1104–1115. doi: 10.1016/j.jhep.2021.05.026.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649. doi: 10.1002/bjs.1800600817.
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470. doi: 10.1053/jhep.2001.22172.
   PubMed Web of Science ®Google Scholar
• Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018–1026. doi: 10.1056/NEJMoa0801209.
   PubMed Web of Science ®Google Scholar
• Liver Failure and Artificial Liver Group CSOID, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure. Zhonghua Gan Zang Bing Za Zhi. 2019;27(1):18–26.
   PubMedGoogle Scholar
• Marcoulides KM, Raykov T. Evaluation of variance inflation factors in regression models using latent variable modeling methods. Educ Psychol Meas. 2019;79(5):874–882. doi: 10.1177/0013164418817803.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang Z, Cheng Q, et al. Establishment and validation of a prognostic model for hepatitis B virus‑related acute-on-chronic liver failure patients with bacterial infection. Hepatol Int. 2022;16(1):38–47. doi: 10.1007/s12072-021-10268-6.
   PubMed Web of Science ®Google Scholar
• Jindal A, Sarin SK. Epidemiology of liver failure in Asia-Pacific region. Liver Int. 2022;42(9):2093–2109. doi: 10.1111/liv.15328.
   PubMed Web of Science ®Google Scholar
• Ramachandran P, Iredale JP, Fallowfield JA. Resolution of liver fibrosis: basic mechanisms and clinical relevance. Semin Liver Dis. 2015;35(2):119–131. doi: 10.1055/s-0035-1550057.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Moreau R, Kamath PS, et al. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers. 2016;2(1):16041. (doi: 10.1038/nrdp.2016.41.
   PubMedGoogle Scholar
• Zaccherini G, Aguilar F, Caraceni P, et al. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. J Hepatol. 2021;74(5):1117–1131. doi: 10.1016/j.jhep.2020.11.035.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Angeli P, Moreau R, et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol. 2021;74(3):670–685. doi: 10.1016/j.jhep.2020.11.048.
   PubMed Web of Science ®Google Scholar
• Zanetto A, Pelizzaro F, Campello E, et al. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis. J Hepatol. 2023;78(2):301–311. doi: 10.1016/j.jhep.2022.09.005.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Moreau R, Jalan R, et al. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol. 2015;62(1 Suppl.):S131–S143. doi: 10.1016/j.jhep.2014.11.045.
   PubMedGoogle Scholar
• Ruiz-MARGáIN A, Pohlmann A, Ryan P, et al. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis. Liver Transpl. 2018;24(5):595–605. doi: 10.1002/lt.25041.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: an evolving chemokine. Cytokine. 2022;153:155828. doi: 10.1016/j.cyto.2022.155828.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992;307(1):97–101. doi: 10.1016/0014-5793(92)80909-z.
   PubMed Web of Science ®Google Scholar
• Li P, Liang X, Luo J, et al. Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study. Lancet Reg Health West Pac. 2023;32:100638. doi: 10.1016/j.lanwpc.2022.100638.
   PubMedGoogle Scholar
• Zhu Y, Li H, Wang X, et al. Hepatitis B virus reactivation increased the risk of developing hepatic failure and mortality in cirrhosis with acute exacerbation. Front Microbiol. 2022;13:910549. (doi: 10.3389/fmicb.2022.910549.
   PubMed Web of Science ®Google Scholar
• Kumar A, DAS K, Sharma P, et al. Hemodynamic studies in acute-on-chronic liver failure. Dig Dis Sci. 2009;54(4):869–878. doi: 10.1007/s10620-008-0421-9.
   PubMed Web of Science ®Google Scholar